中文名 | 5-溴-2-甲基-8-硝基-1,2,3,4-四氢异喹啉 |
---|---|
英文名 | 5-bromo-2-methyl-8-nitro-3,4-dihydro-1H-isoquinoline |
英文别名 |
5-Brom-2-methyl-8-nitro-1,2,3,4-tetrahydroisochinolin
5-bromo-1,2,3,4-tetrahydro-2-methyl-8-nitroisoquinoline 5-Bromo-2-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline 2-methyl 5-bromo-8-nitro-1,2,3,4-tetrahydroisoquinoline Isoquinoline, 5-bromo-1,2,3,4-tetrahydro-2-methyl-8-nitro- 5-bromo-N-methyl-8-nitro-1,2,3,4-tetrahydroisoquinoline Isoquinoline,5-bromo-1,2,3,4-tetrahydro-2-methyl-8-nitro N-methyl 5-bromo-8-nitro-1,2,3,4-tetrahydroisoquinoline |
密度 | 1.5±0.1 g/cm3 |
---|---|
沸点 | 345.7±42.0 °C at 760 mmHg |
分子式 | C10H11BrN2O2 |
分子量 | 271.111 |
闪点 | 162.9±27.9 °C |
精确质量 | 270.000397 |
PSA | 49.06000 |
LogP | 2.40 |
蒸汽压 | 0.0±0.8 mmHg at 25°C |
折射率 | 1.612 |
储存条件 | 2-8°C |
危害码 (欧洲) | Xi |
---|---|
海关编码 | 2933499090 |
~81% 104737-00-0 |
文献:MEMORY PHARMACEUTICALS CORPORATION Patent: US2008/200471 A1, 2008 ; Location in patent: Page/Page column 45; 46 ; US 20080200471 A1 |
~97% 104737-00-0 |
文献:PAINCEPTOR PHARMA CORPORATION Patent: WO2008/144931 A1, 2008 ; Location in patent: Page/Page column 86 ; WO 2008/144931 A1 |
~93% 104737-00-0 |
文献:Rey, Max; Vergnani, Tiziana; Dreiding, Andre S. Helvetica Chimica Acta, 1985 , vol. 68, p. 1828 - 1834 |
~46% 104737-00-0 |
文献:BIGGE, CHRISTOPHER F.; MALONE, THOMAS C.; WATJEN, FRANK Patent: US2003/114422 A1, 2003 ; |
~% 104737-00-0 |
文献:Bigge; Malone; Boxer; Nelson; Ortwine; Schelkun; Retz; Lescosky; Borosky; Vartanian; Schwarz; Campbell; Robichaud; Watjen Journal of Medicinal Chemistry, 1995 , vol. 38, # 19 p. 3720 - 3740 |
~% 104737-00-0 |
文献:Bigge; Malone; Boxer; Nelson; Ortwine; Schelkun; Retz; Lescosky; Borosky; Vartanian; Schwarz; Campbell; Robichaud; Watjen Journal of Medicinal Chemistry, 1995 , vol. 38, # 19 p. 3720 - 3740 |
上游产品 5 | |
---|---|
下游产品 1 | |
海关编码 | 2933499090 |
---|---|
中文概述 | 2933499090. 其他含喹琳或异喹啉环系的化合物〔但未进一步稠合的〕. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |